BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, December 9, 2025
Breaking News: Trump administration impacts continue to roil the life sciences sector
Breaking News: ASH 2025: Casgevy for kids? Expanding, improving SCD gene therapies
Breaking News: Trump administration impacts continue to roil the life sciences sector
Breaking News: Trump administration impacts continue to roil the life sciences sector
Home
»
Topics
» BioWorld Science, Nephrology
BioWorld Science, Nephrology
RSS
Expanded H-BIG clinical development program announced
Aug. 30, 1996
OP-1 role in kidney formation investigated
Aug. 30, 1996
Taisho discloses agents for urinary incontinence
Aug. 30, 1996
Reliance approved for marketing in U.S.
Aug. 30, 1996
Potential BPH therapeutics from Poli Industria Chimica
Aug. 30, 1996
U.S. agreement announced for ProstaFlo
Aug. 30, 1996
Terazosin and finasteride go head-to-head in BPH patients
Aug. 30, 1996
McGill University researchers improve safety of cell therapy
Aug. 23, 1996
Bioniche seeks U.S. approval to begin Cystistat clinical trials
Aug. 23, 1996
Boston Scientific to distribute Urologix technology
Aug. 23, 1996
Previous
1
2
…
318
319
320
321
322
323
324
325
326
327
Next